Okyo Pharma Ltd. company and executive profile by Barron's. View the latest OKYO company infomation and executive bios.

The company forecasts up to $3.1B in 2025 revenue. JP Morgan upgrades Amneal Pharmaceuticals, citing strong Crexont sales, robust generics growth, and a higher 2025 revenue forecast, with peak ...

Explore Salarius Pharmaceuticals stock price, quotes, charts and forecasts with ... Ingevity's North Charleston site; and S&W Seed Company. Salarius Pharmaceuticals (NASDAQ: SLRX) shares are ...

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers ...

BridgeBio Pharma, Inc., a commercial-stage biopharmaceutical company, discovers, creates, tests, and delivers transformative medicines to treat patients who suffer from genetic diseases and cancers.

Real time quote data is not available at this time. *Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green ...

Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy ...